MorphoSys AG announced that it has regained rights to MOR202 from Celgene Corporation (Nasdaq: CELG). The companies have mutually agreed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE